mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |